Association of high-risk human papillomavirus infection duration and cervical lesions with vaginal microbiota composition/Experiment 5
Subjects
- Location of subjects
- China
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Vagina Vagina,vagina,Distal oviductal region,Distal portion of oviduct,Vaginae
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Cervical glandular intraepithelial neoplasia Cervical glandular intraepithelial neoplasia,cervical glandular intraepithelial neoplasia
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- persistent HPV+ with LSIL
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- persistent HPV+ with HSIL
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- persistent HPV+ infection ( same HPV subtype has infected for >12 months) with high grade squamus intraepithelial lesion
Signature 1
Source: Figure 4A
Description: Abundance analysis of the microbiota between high-risk human papillomavirus (HPV) persistent infection with higher-grade squamous intraepithelial lesion (HSIL) and the high-risk HPV persistent infection with lower-grade squamous intraepithelial lesion (LSIL) group
Abundance in Group 1: increased abundance in persistent HPV+ with HSIL
NCBI | Quality Control | Links |
---|---|---|
Streptococcus agalactiae |
Revision editor(s): Cynthia Anderson
Signature 2
Source: Figure 4A
Description: Abundance analysis of the microbiota between high-risk human papillomavirus (HPV) persistent infection with higher-grade squamous intraepithelial lesion (HSIL) and the high-risk HPV persistent infection with lower-grade squamous intraepithelial lesion (LSIL) group
Abundance in Group 1: decreased abundance in persistent HPV+ with HSIL
Revision editor(s): Cynthia Anderson